
The FDA has issued a safety alert, warning of joint pain caused by the gliptins, a common class of drugs …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

